Navigation Links
Third in Biological Technology

BioSpecifics Technologies Corp. to Present at CapStone Investments' Third Annual Small-Cap Investor Conference

LYNBROOK, N.Y., July 22 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming CapStone Inve...

Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results

PALO ALTO, Calif., July 21,/PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) plans to release its financial results for the third quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time (PT) on Wednesday, July 29, 2009. A live webcast (in listen-only mode) of its investor conf...

Nano measurement in the third dimension

This release is available in German . From the motion sensor to the computer chip - in many products of daily life components are used whose functioning is based on smallest structures of the size of thousandths - or even millionths - of millimetres. These micro and nano structures must be...

BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

FRANKLIN LAKES, N.J., June 29 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ) announced today that it will conduct a live webcast of its third fiscal quarter 2009 earnings conference call on Thursday, July 30, 2009 at 10:00 a.m. (EDT). BD will issue a press release d...

WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference

SHANGHAI, June 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) today announced that Edward Hu, the Company's Chief Operating Officer and acting Chief Financial Officer, will present at the Third Annual Jefferies Healthcare Conference in New York on Wednesday, June 17, 2009,...

Delcath Systems Granted Third Orphan Drug Designation

NEW YORK, June 2 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ), a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that the United States Food and Drug Administration ("FDA") granted Delcath's a...

China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results

GANSU, China, May 18 /PRNewswire-Asia-FirstCall/ -- China Dasheng Biotechnology Company ("China Dasheng" or "the Company") (OTC Bulletin Board: CDBT), a leading producer and distributor of organic bacteria based additives for crops and livestock feeds in the PRC, announced unaudited financial ...

Corgenix Reports Third Quarter Fiscal 2009 Financial Results

- Revenues for the quarter increase 4.2% vs. prior year - DENVER, May 14 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, today filed its third quarter Form 10-Q and reported financial results. The r...

YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS

MISSISSAUGA, ON, May 14 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI , TSX:YM, AIM:YMBA), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported operational ...

ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program

CLEVELAND, May 6 /PRNewswire/ -- ChanTest, the leading expert in ion channels and GPCRs (G-protein coupled receptors) -- key to drug discovery, development, and safety -- is one of eight organizations slated to receive funding through Ohio's Third Frontier Research and Commercialization Program. G...

Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results

NEW BRUNSWICK, N.J., May 4 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) today reported financial results for the three months ended March 31, 2009. Net loss for the three month period ended March 31, 2009 was $1,331,477, or $0.07 pe...

Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009

MINNEAPOLIS, April 28 /PRNewswire-FirstCall/ -- Techne Corporation's (Nasdaq: TECH ) consolidated net earnings for the quarter ended March 31, 2009 decreased 6.6% to $27.6 million or $.74 per diluted share compared with $29.6 million or $.76 per diluted share for the quarter ended March 31, 2008...

PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results

- Consolidated service revenue of $264.5 million grows 7.8% year-over-year - Operating margin of 10.0% - Diluted earnings per share of $0.25 - Net quarterly book-to-bill ratio equates to 1.25 BOSTON, April 27 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: ...

Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results

LAVAL, QC, April 14 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) provides guidance for the expected financial results of the fiscal 2009 third quarter and nine-month period ended February 28, 2009. These results represent the year-end...

Neogen Reports Record Third Quarter

LANSING, Mich., March 19 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG ) announced today that despite obstacles posed by the declining global economy, its third quarter revenues increased 11% to $27,840,000, a record third quarter for the 26-year-old company, compared to the prior y...

Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results

BALTIMORE, March 18 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, reports its financial results for the third fiscal quarter ...

US Oncology Named to FORTUNE Magazine's Most Admired Companies List for Third Time

HOUSTON, March 12 /PRNewswire/ -- US Oncology, Inc ., one of the nation's largest cancer care services companies, has been named to FORTUNE magazine's Most Admired Companies list for 2009. The company ranks third in the Health Care: Pharmacy and Other category. This is the third time US On...

Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon

SUNNYVALE, Calif., Feb. 17 /PRNewswire/ -- Avantis Medical Systems, Inc., a technology leader in developing novel chip-on-catheter digital imaging devices, announced today that it has received a new 510(k) clearance for its Third Eye(R) Retroscope(R) (Third Eye), supporting the claim for increased...

On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability

ANN ARBOR, Mich., Feb. 10 /PRNewswire/ -- Compendia Bioscience, Inc. today announced the results of a third productive year, including a 100 percent renewal rate from its customers. New customers and increased commitments from existing customers, including multi-year agreements from three of the T...

Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008

TOKYO, February 5 /PRNewswire-FirstCall/ -- HOYA Corporation today announced financial results for the third quarter ended December 31, 2008. Net sales were 112.7 billion yen for the quarter, representing a decrease of 23.3% from 147.0 billion yen in the third quarter of 2007, mainly due to or...

Repligen Reports Third Quarter Fiscal Year 2009 Financial Results

WALTHAM, Mass., Feb. 5 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) today reported results for the third quarter of fiscal year 2009, ended December 31, 2008. Total revenue for the quarter was $6,018,000 compared to $4,664,000 for the third quarter of fiscal year 2008. Total ...

Uroplasty Reports Third Quarter Fiscal 2009 Results

MINNEAPOLIS, Feb. 3 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the third quarter of fiscal 2009 ended December 31,...

Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results

Thursday, February 5th, 10:00 a.m. EST WALTHAM, Mass., Jan. 29 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, February 5th,...

Abaxis to Report Third Quarter Fiscal 2009 Financial Results Thursday, January 29, 2009

UNION CITY, Calif., Jan. 22 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the third quarter of fiscal year 2009, ended December 31, 2008. ...

Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso

REHOVOT, Israel, JERSEY CITY, New Jersey and PHILADELPHIA, Pennsylvania, December 29 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), the leading developer of microRNA-based molecular diagnostics, announced today the introduction of its third diagnostic test, miRview(TM) meso. T...

Probiotic Delivery Technology Awarded Third International Patent

REDMOND, Wash., Dec. 16 /PRNewswire/ -- The Australian Patent Office has issued Nutraceutix, Inc. a patent for BIO-tract. It is the third international patent, from many patents pending, that the technology has been awarded based on BIO-tract's ability to protect sensitive ingredients like probiot...

Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS

REHOVOT, Israel and JERSEY CITY, New Jersey, December 5 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG ), an innovative molecular diagnostic company leveraging microRNAs as biomarkers, reported today its consolidated financial results for the quarter ended September 30, 2008 ...

Ernst & Young Benchmarks Danish Biotech Pipeline Third in Europe

COPENHAGEN, December 1 /PRNewswire/ -- A strong pipeline makes the Copenhagen Region biotech cluster well prepared for the challenges ahead. With 185 drug candidates in preclinical and clinical development, Denmark ranks third in Europe. Only United Kingdom and Germany have a bigger pipeline. ...

Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing

WAYNE, Pa., Nov. 28 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that on Novemb...

Encorium Reports Third Quarter 2008 Financial Results

-- New business wins increase 400% to $16 million in third quarter 2008; up 40% year-to-date -- Results include $1.9 million non-cash goodwill impairment charge WAYNE, Pa., Nov. 26 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ) , a full service multinational c...

Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results

REHOVOT, Israel and JERSEY CITY, New Jersey, November 26 /PRNewswire-FirstCall/ -- Rosetta Genomics (Nasdaq: ROSG ), today announced it will release third quarter financial results on December 5, 2008, before the U.S. markets open. Rosetta Genomics will host a conference call with a simultan...

Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results

LA JOLLA, Calif., Nov. 20 /PRNewswire-FirstCall/ -- Duska Therapeutics, Inc. (OTC Bulletin Board: DSKA) will host a teleconference call today at 2:30 p.m. EST to review its drug development programs and financial results for the third quarter of 2008. Duska's chief executive officer, James S. Kuo,...

Sinovac Reports Third Quarter 2008 Unaudited Financial Results

BEIJING, Nov. 18 /PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA ), a leading developer and provider of vaccines in China, today announced the Company's financial results for the three-month and nine-month periods ended September 30, 2008. Highlights -- Sales year-to-date increased ...

Benda Pharmaceutical Reports Third Quarter 2008 Financial Results

HUBEI PROVINCE, China, Nov. 18 /PRNewswire-FirstCall/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, ...

Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results

Conference Call To Be Held Friday, November 14, 2008 at 9:00 a.m. Eastern Time HOPKINTON, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE ) today reports operational and financial results for the quarter ended September 30, ...

Pharmathene Reports Third Quarter 2008 Financial and Operational Results

ANNAPOLIS, Md., Nov. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Alternext US: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results for the third quarter and nine months ended September ...

Interleukin Genetics Reports Third Quarter 2008 Financial Results

WALTHAM, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI ) today announced financial and business results for the third quarter ended September 30, 2008. The Company reported a net loss of $1.6 million, or $(.05) per basic and diluted common share, for the thi...

Cardiogenesis Reports Third Quarter 2008 Results

IRVINE, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients suffering from severe angina, today reported financial results for its third quarter ended September 30, 2008. Third Qua...

AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results

All amounts are in U.S. dollars QUEBEC CITY, Nov. 13 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS , TSX: AEZ), a global biopharmaceutical company focused on endocrinology and oncology, today reported financial and operating results for the third quarter ended September 30, 2...

Yongye Biotechnology Announces Record Third Quarter Results

BEIJING, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals in the People's Republic of China, today announced its financial r...
Other Tags
(Date:7/23/2014)... that has the entire country in its grip is affecting ... be responsible for the proliferation of a heat-loving amoeba commonly ... hot springs, which the drought has made warmer than usual ... an infection caused by this parasite after swimming in several ... of an individual and travels to the brain. Nose plugs ...
(Date:7/23/2014)... The planet,s soil releases about 60 billion tons of ... more than that released by burning fossil fuels. This ... release of carbon is balanced by carbon coming into ... matter, as well as by the underground activities of ... that rising temperatures increase the rate of soil respiration. ...
(Date:7/23/2014)... Non-biting blow fly Chrysomya megacephala is commonly ... investigations to determine the time of death, referred to ... derived form of C. megacephala from Tamil ... morphological features and molecular characterization through generation of DNA ... in the open access Biodiversity Data Journal . ...
Breaking Biology News(10 mins):Diseases of another kind 2Climate change and the soil 2Dead body feeding larvae useful in forensic investigations 2
(Date:7/23/2014)... (PRWEB) July 23, 2014 Obtaining insurance ... for the average consumer. The Quotes Pros company is ... all 50 states this year to make research faster ... are issuing the rates information are actual agencies that ... underwritten inside the U.S. An advantage to adults who ...
(Date:7/23/2014)... July 23, 2014 The National ... today a robust trial for a defined period ... risk adjusting relevant quality measures for sociodemographic factors, ... policy.     , Sociodemographic factors can be socioeconomic, e.g., ... ethnicity, and primary language. Growing evidence shows ...
(Date:7/23/2014)... Edmond, Oklahoma (PRWEB) July 23, 2014 ... North America’s leading provider of in-home care for ... Healthy Longevity Webinar Series featuring experts in a ... upcoming webinar will feature licensed clinical social worker ... the most common causes of caregiver stress and ...
(Date:7/23/2014)... 23, 2014 A new study has ... morcellator ( http://www.injurybeacon.com/power-morcellator/ ) during minimally invasive hysterectomies ... a woman’s body, Bernstein Liebhard LLP reports. The research, ... of the American Medical Association, looked at 36,000 women ... 500 U.S. hospitals from 2006 to 2012. Ninety-nine of ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... A powerful drug combo may not be as effective ... on human cells suggests that one of the medications ... this study,s findings aren,t definitive, and there,s still hope ... and lumacaftor, according to the study,s senior author. ...
Breaking Medicine News(10 mins):Health News:Term Life Insurance Prices for All 50 States Now Explored at Insurer Website 2Health News:NQF Board Approves Trial Period to Test Impact of Risk Adjustment of Performance Measures for Sociodemographic Factors 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3
Other Contents